Regulatory Affairs for Biomaterials and Medical Devices 2015
DOI: 10.1016/b978-0-85709-542-8.50013-9
|View full text |Cite
|
Sign up to set email alerts
|

List of contributors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…3,20 However, their clinical applications remain limited because of uncertain efficacy and prolonged preclinical tests. 2 Consequently, new strategies are urgently required to solve these problems.…”
mentioning
confidence: 99%
“…3,20 However, their clinical applications remain limited because of uncertain efficacy and prolonged preclinical tests. 2 Consequently, new strategies are urgently required to solve these problems.…”
mentioning
confidence: 99%